BioInsights - Biomanufacturing I-O therapeutics in the 21st century

Biomanufacturing I-O therapeutics in the 21st century

Immuno-Oncology Insights 2021; 2(6), 345–348

10.18609/ioi.2021.041

Published: 29 November 2021
Editorial
Gregory Zarbis-Papastoitsis

“...there is a drive to switch from batch to continuous processing where efficient intergradation of the units of operation, monitoring and control of the process and the product are achieved.”